Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis
Saved in:
Main Authors: | Salugina SO (Author), Fedorov ES (Author), Alexandrova EN (Author), Novikov AA (Author), Cherkasova MV (Author), Baranov AA (Author), Valogina YA (Author), Nikolaeva TN (Author), Zubova NA (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2008-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
by: Guseinova D, et al.
Published: (2008) -
Features of Clinical and Laboratory Parameters in Children with Arthritis, which Have Increased Antibody Titers to Cyclic Citrullinated Peptide and Modified Citrullinated Vimentin
by: I.S. Lebets, et al.
Published: (2013) -
Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis in comparison with other rheumatic diseases; a nephrology point of view
by: Alireza Sadeghi, et al.
Published: (2017) -
Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis
by: Bo Li, et al.
Published: (2008) -
Cryopyrin-associated periodic syndromes (CAPS): report on two cases (Muckle-Wells syndrome (MWS) and CINCA/NOMID)
by: Kuzmina NN, et al.
Published: (2011)